Investment & Finance
Building the Future of Life Sciences, One Phase at a Time
Building the Future of Life Sciences, One Phase at a Time
DLS Group is executing a multi-phase strategic investment plan aimed at expanding research capacity, building biotech infrastructure, and accelerating product commercialization. These investments reflect our long-term commitment to innovation, global health, and sustainable biotechnology growth.
Investment Amount: USD 200 million (or equivalent in NTD)
Duration: 1 year
Purpose:
- Expansion of the Taiwan R&D Center
- Integration of advanced biotechnology platforms and facilities
Investment Amount: USD 4.8 million
Duration: 1 year
Purpose:
- Establishment of a Biotechnology Park R&D Center
- Construction of production facilities and marketing units for mature biotech products in the DLS pipeline.
Investment Amount: USD 5.0 million
Duration: 2 year
Purpose:
- Introduction of new technologies and continuous R&D
- Mass production of new products within the biotech park
Investor Relations
Four Planning & Management Units:
We welcome global investors, institutional partners, and strategic collaborators to explore partnership opportunities.
Our investment roadmap includes:
- Clear financial projections with defined ROI timelines
- Trackable development milestones in R&D, infrastructure, and commercialization
- A transparent, scalable long-term growth strategy rooted in real-world biotech impact
Get free quote
Need Help?
If you need any helps,please feel free to contact us.
